Please login to the form below

Lyxumia

This page shows the latest Lyxumia news and features for those working in and with pharma, biotech and healthcare.

Sanofi wins EU approval for new diabetes combination Suliqua

European Commission licenses the once-daily version of Lantus and Lyxumia. Sanofi's combination therapy Suliqua has been granted European marketing approval for the treatment of adults with type 2 diabetes. ... The dual-drug treatment combines the firm's

Latest news

Sanofi launches insulin combo Soliqua in US

Diabetes drug available in pharmacies for $127 per 300 unit pen ahead of Novo Nordisk's Xultophy
FDA clears rival diabetes combos from Sanofi and Novo Nordisk

Adlyxin/Lyxumia (lixisenatide).
Gilead's hepatitis B virus treatment set for European approval

Sanofi's lixisenatide-only drug Lyxumia has been on the market in Europe since 2013 and was approved in the US by the FDA as Adlyxin in July this year.
Sanofi trumpets new IGlarLixi data after regulatory delay

Lyxumia (lixisenatide) - helped more patients with type 2 diabetes reach post-prandial glucose targets than Lantus.
Sanofi loses lead on diabetes combo IGlarLixi after FDA delay

Lyxumia (lixisenatide), and has extended its review period by three months.

More from news
Approximately 12 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Deal Watch October 2018

Suliqua &Lyxumia/ Adlyxin for Type 2 diabetes. Purchase of. royalty rights.
Interview: Pierre Chancel, Sanofi Diabetes

Key among these for Sanofi is Lyxumia (lixisenatide), the company's new GLP-1 receptor agonist, which is planned for first launch in Germany following European approval and has been accepted ... With a single daily injection and only one step to

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

Roche’s Torsten Hoffmann to join Zealand Pharma

Its lead product is the GLP-1 agonist lixisenatide, which is licensed to Sanofi who markets it as Lyxumia for the treatment of type 2 diabetes.
Agneta Svedberg appointed COO at Zealand Pharma

The appointment comes at crucial time for Zealand, with its diabetes partnership with Sanofi set to pay off as the big pharma company gears up to launch Lyxumia (lixisenatide) this year.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Medical Writers > Scientific Directors – Medical Communicatio...: Highly Competitive Salary, Bonus &Benefits

HR Manager – Recruitment/ Generalist combined role, Marketing ag...: circa £50K

Senior Medical Writer – Creative Healthcare Advertising – New Yo...: Highly Competitive Salary, Bonus &Benefits

PR/ PA Account Executive (UK Healthcare Industry specialist, cam...: Competitive

Client Services Director, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Senior Account Exec > CSD – Medical Communications – UK, Lond...: Highly Competitive Salary, Bonus &Benefits

Account Supervisor – Leading Healthcare Advertising Agency – New...: Highly Competitive Salary, Bonus &Benefits

B2B media account director: Competitive salary

Vaccines writer – career opportunity to move into medcomms from ...: Highly competitive salary

Principal Medical Writer, MRNA/ Covid 19, Medical Communications...: Highly competitive salary

Scientific Director, MRNA/ Covid 19, Medical Communications, UK: Six figure salary

PMHub

Add my company

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs: In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?: Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:: Securing a future for telehealth with immersive market research insights...

Email:
Password:

Please login to the form below

Lyxumia

COVID-19 Updates and Daily News

Featured jobs

Quick links